A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus

A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus

The human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide. People living with the human immunodeficiency virus (HIV) are at high risk of HPV infection. This systematic review evaluates the immunogenicity, clinical efficacy, and safety of prophylactic HPV vaccines...

Full description

Bibliographic Details
Main Authors:	Edison J. Mavundza, Alison B. Wiyeh, Phetole W. Mahasha, Gregory Halle-Ekane, Charles S. Wiysonge
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-02-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	human papillomavirus human immunodeficiency virus quadrivalent hpv vaccine bivalent hpv vaccine
Online Access:	http://dx.doi.org/10.1080/21645515.2019.1656481

Similar Items

Investigation on Spontaneous Abortion and Human Papillomavirus Infection
by: Mauro Tognon, et al.
Published: (2020-08-01)

Human papillomavirus prevalence, genomic diversity and related risk factors in HIV-positive women from a countryside city in the state of Rio de Janeiro
by: Charbell Miguel Haddad Kury, et al.
Published: (2021-03-01)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
by: Juan J. Hernandez-Aguado, et al.
Published: (2022-03-01)

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
by: Macey L. Murray, et al.
Published: (2018-11-01)

Human papillomavirus vaccination: An important tool in cervical cancer elimination
by: Veena Pampapati, et al.
Published: (2020-01-01)

Human papillomavirus vaccination at the first opportunity: An overview
by: Robert A. Bednarczyk, et al.
Published: (2023-01-01)

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop
by: Anne E. Schuind, et al.
Published: (2023-10-01)

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population
by: Trisha L. Amboree, et al.
Published: (2022-08-01)

Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
by: Loredana Sabina Cornelia Manolescu, et al.
Published: (2022-10-01)

Defining Elimination of Genital Warts—A Modified Delphi Study
by: Laila Khawar, et al.
Published: (2020-06-01)

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
by: Darron R. Brown, et al.
Published: (2022-06-01)

Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
by: Mallory K. Ellingson, et al.
Published: (2023-08-01)

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
by: Ingrid Herta Rotstein Grein, et al.
Published: (2020-11-01)

Human papillomavirus vaccination in adults: impact, opportunities and challenges – a meeting report
by: Dur-e-Nayab Waheed, et al.
Published: (2021-08-01)

The effect of perceived psychological stress on the immunogenicity of the quadrivalent human papillomavirus vaccine in males
by: Rebecca F. Wu, et al.
Published: (2017-03-01)

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
by: Richard Gilson, et al.
Published: (2020-09-01)

Human papillomavirus vaccine uptake in South Korea
by: Jin Young Choi, et al.
Published: (2022-01-01)

Involvement of Human Papillomaviruses in Cervical Cancer
by: Xuelian Wang, et al.
Published: (2018-11-01)

Cervical Cancer and Human Papillomavirus Awareness among Women in Saudi Arabia
by: Khalid Akkour, et al.
Published: (2021-12-01)

An opportunity to increase human papillomavirus vaccination rates: Change the guidelines
by: Abraham Aragones, et al.
Published: (2022-11-01)

Geographical disparities in human papillomavirus herd protection
by: Abbey B. Berenson, et al.
Published: (2020-07-01)

Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia
by: Fatemah A. Alherz, et al.
Published: (2024-05-01)

Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings
by: Emmanuel Timmy Donkoh, et al.
Published: (2022-06-01)

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
by: Supitcha Kamolratanakul, et al.
Published: (2021-11-01)

Human Papillomavirus-Associated Cancers in Georgia, 2008-2012
by: Irene Solomon, et al.
Published: (2016-04-01)

Effectiveness of HPV vaccination in reducing infection among young Brazilian women
by: Ana Carolina da Silva Santos, et al.
Published: (2025-01-01)

Cervical Cancer Prevention with HPV Vaccines
by: Chaivanee Kaosayapandhu
Published: (2017-04-01)

Bibliometric Analysis of The Scientific Literature on Human Papillomavirus Vaccine Clinical Trials: Analysis of PubMed Database
by: Sushmitha Mohana Murali, et al.
Published: (2023-07-01)

Exploration of the effect of human papillomavirus (HPV) vaccination in a cohort of pregnant women in Montreal, 2010–2016
by: El Hadji Malick Sarr, et al.
Published: (2019-08-01)

Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study
by: Yu Liu, et al.
Published: (2023-07-01)

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands
by: Tessa M. Schurink‐van ’t Klooster, et al.
Published: (2023-05-01)

Evaluation of knowledge and attitudes of the faculty of medicine students about human papillomavirus infections, related cancers, and human papillomavirus vaccines
by: Zührenur Yağan, et al.
Published: (2023-04-01)

Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023
by: Zian Lin, et al.
Published: (2024-01-01)

National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol
by: Matthew Palmer, et al.
Published: (2021-05-01)

Interconnectedness threat: unveiling the mechanisms behind human papillomavirus-induced cervical cancer
by: Racheal Ahuoyiza Ayeni, et al.
Published: (2025-03-01)

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
by: David Mesher, et al.
Published: (2016-10-01)

Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen
by: Robert A. Bednarczyk, et al.
Published: (2023-01-01)

Parents’ Knowledge and Attitude towards HPV and HPV Vaccination in Poland
by: Katarzyna Smolarczyk, et al.
Published: (2022-02-01)

Ten years of anti-HPV vaccinations: what do we know?
by: Robert Jach, et al.
Published: (2016-11-01)

Overview of the Global Vaccination against Human Papillomavirus
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01)